Investment Rating - The report maintains an "Overweight" rating for the beauty care industry, indicating an expectation that the industry index will outperform the market index by more than 10% over the next six months [29]. Core Insights - The beauty care industry is experiencing a simultaneous increase in demand and pressure on profitability, leading to intensified industry differentiation. Companies are shifting focus from scale expansion to profit orientation, with a structural divergence expected in the short term. However, there is potential for recovery in the medium to long term due to increased concentration among leading companies and product strength [29]. - The retail sales of cosmetics reached 75.3 billion yuan in January-February 2026, marking a year-on-year growth of 4.5%, which outperformed the overall market and reflects a steady growth trend [21][23]. - The overall price-to-earnings ratio (PE) of the beauty care industry is approximately 32.46 times, which is below the valuation mean since 2015, indicating a potential undervaluation [20]. Summary by Sections Market Review - The SW beauty care industry underperformed the CSI 300 index, declining by 1.52% from March 6 to March 19, 2026, and ranked fifteenth among SW primary industries [13]. - All secondary segments within the beauty care industry recorded negative returns during the same period, with personal care products, cosmetics, and medical beauty declining by 1.56%, 2.27%, and 2.30%, respectively [14]. - Approximately 29.03% of stocks in the industry recorded positive returns, with Keshihua leading with a 5.62% increase, while Shuiyang shares saw the largest drop at 10.32% [15]. Industry News - The growth of the skincare and beauty business by Ryohin Keikaku (Muji) has doubled its revenue to approximately 100 billion yen, accounting for about 13% of total sales, becoming a significant growth driver [24]. - Intercos, a leading global beauty OEM, reported a 1.7% decline in revenue for 2025, marking its first annual revenue drop since its IPO in 2021, although its adjusted EBITDA increased by 8.8% [25]. Company Announcements - Aimeike reported a revenue of 2.453 billion yuan for 2025, down 18.94% year-on-year, with a net profit of 1.291 billion yuan, a decrease of 34.05% [26]. - Juzi Biotechnology achieved a revenue of 5.519 billion yuan for 2025, a slight decline of 0.4%, with a net profit of 1.915 billion yuan, down 7.1% [27]. - Shuiyang shares are nearing conditions for redeeming convertible bonds, reflecting marginal improvements in operations and market expectations [28]. Weekly Industry Perspective - The report emphasizes the ongoing structural optimization in the beauty care industry, with a shift from scale expansion to profit quality enhancement. It suggests focusing on leading companies with strong brand and cash flow advantages, such as Huaxi Biological, Wanmei Biological, Beijia Clean, and Shanghai Jahwa, to capture structural opportunities [29][30].

Investment Rating - The report maintains a "Positive" outlook on international cosmetics and medical beauty companies for 2025 [2]. Core Insights - The global beauty market is expected to grow at a slow pace of 3.5% in 2025, down from 4.5% in 2024 and 8% in 2023, indicating a continued decline in demand [3][13]. - In the Chinese market, the cosmetics retail sales growth is projected to improve to 5.1% in 2025, recovering from negative growth in 2024, with international brands seeing a resurgence [3][18]. - Major international companies like L'Oréal and Procter & Gamble are expected to show stable growth, while others may face revenue pressures [3][14]. Summary by Sections 1. Global Beauty Market Performance - The global beauty market is stabilizing after a period of decline, with a growth rate of 3.5% in 2025 [3][13]. - Demand-side weaknesses continue to challenge international groups, necessitating strategic adjustments [14]. 2. L'Oréal's Performance - L'Oréal's revenue growth for 2025 is projected at 1.3%, with a slight improvement in Q4 compared to Q3 [3][24]. - The company is focusing on brand acquisitions and enhancing its online presence in China to adapt to market changes [21][24]. 3. Estée Lauder's Strategy - Estée Lauder's overall revenue for 2025 is expected to be $14.67 billion, reflecting a 3.3% decline year-over-year, but Q4 shows a positive growth trend [3][47]. - The company is implementing strategic reforms to address previous challenges, particularly in the Chinese market [44][47]. 4. Shiseido's Challenges - Shiseido's revenue is forecasted to decline by 2.1% in 2025, with operating profit turning negative [3][17]. - The company is experiencing fluctuations in performance, particularly in the Chinese market, which is expected to remain volatile [3][18]. 5. Investment Recommendations - The report recommends focusing on companies with strong channel and brand matrices, such as Mao Ge Ping and Shangmei, as well as those with improving performance like Proya and Marubi [4]. - In the medical beauty sector, companies with strong R&D capabilities and product pipelines, such as Aimeike and Langzi, are highlighted as potential investment opportunities [4].

Investment Rating - The report maintains a "Buy" rating for Shanghai Jahwa [5] Core Insights - Shanghai Jahwa, a century-old domestic personal care brand, is undergoing a strategic reform aimed at improving operational quality, with a revenue of 4.961 billion yuan in Q1-Q3 2025, representing a year-on-year increase of 10.8%, and a net profit of 405 million yuan, up 149.1% year-on-year [2][3] Summary by Sections 1. Company Overview - Shanghai Jahwa is a century-old domestic personal care group with a diverse portfolio covering skincare, personal care, and maternal and infant products, including 15 brands such as Six God and Bai Cao Ji [2][18] - The company has undergone significant changes since its establishment in 1898, including a complete acquisition by Ping An Trust in 2011, making Ping An the actual controller [18][21] 2. Reform Progress - The company has restructured its organizational framework to focus on brand-centric strategies, introducing experienced external managers to enhance brand operations [3][30] - Brands are categorized into three tiers for resource allocation: Tier 1 (Six God, Yu Ze), Tier 2 (Bai Cao Ji, Mei Jia Jing), and Tier 3 (Gao Fu, Qi Chu, Shuang Mei) [3][34] - The supply chain has been optimized by reclaiming some OEM product lines to improve capacity utilization [3][40] 3. Outlook - The company aims to establish a "billion-yuan product club" to leverage brand resources and operational experience, targeting the creation of 10 billion-yuan products in the near term [11] - Revenue projections for 2025-2027 are 6.488 billion, 7.579 billion, and 8.421 billion yuan, with net profits of 261 million, 535 million, and 666 million yuan respectively [4][11] 4. Financial Analysis - The financial forecast indicates a recovery in revenue and profitability, with a projected net profit turnaround in 2025 [4][11] - The earnings per share (EPS) are expected to be 0.39, 0.80, and 0.99 yuan for 2025, 2026, and 2027 respectively, with corresponding price-to-earnings (PE) ratios of 54X, 26X, and 21X [4][11] 5. Investment Recommendations - The report suggests that the company's reform strategies are beginning to yield results, with improved brand management and operational efficiency expected to drive future growth [12][14]

Market Strategy - The report indicates that overseas disturbances have intensified, leading to a significant adjustment in the market [5][10] - The A-share market saw a decline, with the Shanghai Composite Index falling by 1.39% to 4006.55 points, and the ChiNext Index dropping by 1.11% to 3309.10 points [7][10] - The report highlights that the overall market sentiment is affected by external macroeconomic events, particularly the Middle East energy crisis and the Federal Reserve's stance on interest rates [10] Industry Dynamics - The price of photovoltaic polysilicon has decreased month-on-month, with transaction activity remaining subdued. The average transaction price for n-type polysilicon is reported at 43,200 CNY per ton, down 4.42% [25][26] - In the first two months of 2026, production of copper, aluminum, lead, and zinc showed a majority year-on-year increase, with refined copper production at 2.473 million tons, up 9% [27] - The report notes that the aluminum sector experienced a mixed performance, with aluminum production declining by 4.2% to 948.6 thousand tons, while aluminum alloy production increased by 8.9% to 276.5 thousand tons [27] Company Updates - Shanghai Shangmei Cosmetics Co., Ltd. has signed a strategic cooperation framework agreement with Suzhou Kaituo Pharmaceutical Co., Ltd. regarding the commercialization of the whitening agent KT-939 [28][29] - Guotou Securities is set to acquire a 5.93% stake in Anxin Fund from China General Nuclear Power Financial, increasing its ownership to 39.88% and becoming the largest shareholder [30][31] - Dao Dao Quan (002852.SZ) reported a revenue of 6.195 billion CNY for 2025, a year-on-year increase of 4.24%, with a net profit of 234 million CNY, up 32.02% [32][33]

Core Viewpoint - KATE, a classic makeup brand under Kao Group, will officially close its Tmall and Douyin flagship stores on April 1, 2026, due to strategic upgrades and business adjustments [3][6][12]. Summary by Sections Store Closure Announcement - KATE has announced the closure of its Tmall flagship store, effective April 1, 2026, as part of a strategic upgrade and business layout adjustment [6][12]. - The brand has provided clear arrangements for consumer rights, including refund processes for unused balance and points, which must be claimed by March 31, 2026 [4][6]. Consumer Rights and Services - Customers can place valid orders until 5:00 PM on March 31, 2026, and will continue to receive after-sales services, including a 7-day return policy, until April 30, 2026 [4][7]. - Customer service will remain available until April 30, 2026, for inquiries and support regarding existing orders [7]. Brand Background and Market Position - KATE was established in 1997 and is known for its high cost-performance ratio, being recognized as a pioneer in affordable Japanese cosmetics [10]. - The brand has a significant online presence, with 2.3 million followers on Tmall, making it the largest online platform for KATE [8]. Future Brand Strategy - Kao Group's decision to close the Tmall flagship store is part of a broader strategic adjustment, focusing on high-end product development and optimizing business resources [12]. - The overseas flagship store will continue to operate on Tmall, allowing consumers to purchase KATE products through that channel [12].

近日，花王集团旗下经典彩妆品牌KATE凯朵，接连在 抖音官方旗舰店、天猫官方旗舰店发布 闭店告知书， 宣布店铺将于2026年4月1日起正式闭店 。 消息一出，瞬间在社交平台掀起了一场集体怀旧热潮，无数网友直呼"我的青春结束了"。 【凯朵/KATE】闭店告知书 尊敬的各位顾客与品牌挚友: 妻心感谢您长久以来对【凯朵/KATE】品牌的信任、喜爱与一路相伴!因品牌战略 升级与业务布局调整,经过慎重考量,我们遗憾地宣布【凯朵/KATE】天猫官方旗舰店 (下称"店铺")将正式启动闭店流程,并于2026年4月1日起正式闭店、停止旗舰 店商品销售业务。 为保证您的合法权益,现特将闭店核心时间节点与权益保障相关内容说明如下: 1.最后下单时间 您在2026年3月31日17:00前下单并完成付款的订单为有效订单,店铺将按序履 行发货义务。您可通过平台订单页查询该订单的物流信息; 2.会员权益处理 | 对于您未使用完毕的品牌储值余额、优惠券、积分店铺安排如下: 1储值余额:店铺将统一安排退款; 2会员积分:请您于2026年3月31日前联系店铺客服申请积分兑换,逾期仍未兑 换的积分将失效。 3优惠券:请您于闭店前使用完毕,闭店后未 ...

Investment Rating - The industry investment rating is "Positive" [10] Core Insights - The report highlights strong performance in the beauty and personal care sector, particularly in the medical aesthetics and cosmetics segments, with notable revenue growth and profitability in key companies [9][41] - The report emphasizes the importance of emotional consumption and the demand for innovative products that meet consumer needs, particularly in the context of domestic brands gaining market share [44][45] Summary by Sections Market Review - The beauty care index rose by 2.75% in February, outperforming the broader market [15] - In the medical aesthetics sector, companies like Huahan Co. and Pumen Technology saw significant stock price increases, while in cosmetics, Qing Song Co. and Beitaini led the gains [6][25] Medical Aesthetics Performance - Jinbo Bio reported a revenue of 1.595 billion yuan for 2025, a year-on-year increase of 10.57%, but a net profit decline of 11.08% due to increased costs and strategic adjustments [7][31] - Huaxi Bio's revenue for 2025 was 4.217 billion yuan, down 21.49%, while net profit surged by 67.03% due to cost management and strategic realignment [34][34] Cosmetics Performance - The 38 promotional event showcased strong performance for domestic brands, with significant sales figures reported from live streaming channels [8][36] - Upme Co. projected a revenue of 9.1-9.2 billion yuan for 2025, reflecting a growth of 34.0%-35.4%, driven by its successful brand strategy [41][41] Investment Recommendations - The report recommends focusing on high-quality companies in the medical aesthetics and cosmetics sectors that cater to emotional consumption trends, highlighting companies like Meili Tianyuan Medical Health and Aimeike [9][44] - In cosmetics, brands that innovate with emotional value and safe ingredients are favored, with recommendations for companies like Porlaia and Upme Co. [45][46]

Investment Rating - The industry investment rating is "Overweight" [48] Core Insights - The report highlights strong performance in the domestic beauty and medical aesthetics sectors, with notable revenue growth and profit improvements for key companies [4][41] - The report emphasizes the importance of emotional consumption and the demand for innovative products in the beauty industry, particularly among domestic brands [44][45] Summary by Sections Market Review - In February, the beauty care index rose by 2.75%, outperforming the broader market [13] - Notable stock performances included Huahan Co. (+3.4%) and Pumen Technology (+2.5%) in the medical aesthetics sector, while Qingsong Co. (+16.6%) and Beitaini (+12.5%) led in the cosmetics sector [3][18][23] Medical Aesthetics - Jinbo Bio reported a 2025 revenue of 1.595 billion yuan, a 10.57% increase year-on-year, but a net profit decline of 11.08% due to increased R&D and marketing costs [4][29] - Huaxi Bio's revenue fell by 21.49% to 4.217 billion yuan, while net profit surged by 67.03% due to cost management and non-recurring gains [4][32] Cosmetics - The 38 promotional event saw strong sales for domestic brands, with significant performance from brands like Porlaia and Beitaini [5][36] - Upcoming earnings for Shumei Co. are projected to show a revenue increase of 34.0%-35.4% and a net profit growth of 41.9%-44.4% [41] Investment Recommendations - The report recommends focusing on high-quality companies in the medical aesthetics sector that are expanding their market presence, such as Meilitiantian Medical Health and Aimeike [6][44] - In cosmetics, it suggests investing in brands that emphasize emotional value and innovative ingredients, highlighting companies like Porlaia and Shumei Co. [45][47]

Group 1 - The Guangzhou Market Supervision Administration announced an investigation into the Kangaroo Mom Group regarding allegations related to cosmetic sales [2] - A verification team was established, and on-site inspections were conducted, confirming that the company's production practices are compliant [2] - Over the past three years, 38 batches of the company's cosmetics were sampled by market supervision departments, all meeting the requirements of the "Cosmetic Safety Technical Specifications" [2] Group 2 - The administration criticized the company for inappropriate marketing statements and urged it to implement corrective measures [2] - The Guangzhou Market Supervision Administration will continue to strengthen supervision and inspection of cosmetic companies to ensure compliance and safeguard consumer safety [2] - The administration expressed gratitude for the public's concern and supervision regarding the quality of cosmetics in Guangzhou [2]

Core Viewpoint - The Chinese cosmetics industry is projected to reach a market size of 1.1 trillion, with domestic brands surpassing international brands in market share and consumer preference significantly increasing for domestic products [1][2]. Group 1: High-Quality Development and New Productive Forces - The high-quality development of the beauty and skincare industry relies on the cultivation and implementation of new productive forces, which are essential for transitioning from traditional manufacturing to intelligent and lean production [4]. - New productive forces enhance production logic by utilizing automation and intelligent equipment to address batch fluctuations and quality control issues, thereby improving production efficiency and product consistency [4]. - These forces also align with consumer upgrade demands, facilitating product innovation that shifts from "concept marketing" to "technology empowerment" [4]. Group 2: Intelligent Manufacturing Practices of Domestic Brands - Over the past decade, the beauty and skincare manufacturing industry has transitioned from experience-driven to data-driven upgrades, establishing a clear three-stage evolution path [6]. - The current stage is characterized by intelligent data-driven systems that enable full-process traceability and flexible collaboration, meeting the industry's demands for rapid product iteration and compliance [6]. - Leading brands like Han Shu and Hua Xi have made significant investments in intelligent manufacturing, achieving production capacity increases and quality control improvements that rival international brands [10][15]. Group 3: R&D Innovation and Cost Investment - R&D expenditure rates vary across categories, with skincare products averaging 1.5%-3% and medical beauty products ranging from 2%-5%, indicating a stratified investment landscape driven by product attributes and technological barriers [19][20]. - Domestic brands like Hua Xi and Bei Tai Ni have significantly increased their R&D personnel ratios, aligning closely with international brands, showcasing their commitment to innovation and development [21][22]. - The production cost rates for various product categories range from 15% to 30%, with domestic brands leveraging self-researched technologies and integrated supply chains to maintain competitive pricing while ensuring quality [25][27]. Group 4: International Competitiveness of Domestic Brands - Domestic beauty brands, exemplified by Han Shu, Peiliya, and Bei Tai Ni, have achieved comprehensive breakthroughs in core competitiveness through new productive forces [28]. - The implementation of intelligent manufacturing has enabled micro-level quality control, establishing trust barriers in product quality [30]. - The integration of AI-driven workshops and 5G smart factories has positioned domestic brands at the forefront of technological advancement and operational efficiency, contributing to the high-quality development of China's beauty and skincare industry [30].